Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
57.2 SEK | -1.04% | -7.74% | +25.30% |
May. 02 | Integrum Expands Its Product Offering to the United Kingdom Market | CI |
Mar. 26 | Integrum Enters a Commercial agreement with AMI Technologies to introduce the OPRATM Implant System in Israel | CI |
Sales 2024 * | 107M 9.86M | Sales 2025 * | 151M 13.92M | Capitalization | 1.07B 98.19M |
---|---|---|---|---|---|
Net income 2024 * | 3M 276K | Net income 2025 * | 15M 1.38M | EV / Sales 2024 * | 9.75 x |
Net cash position 2024 * | 22.09M 2.04M | Net cash position 2025 * | 18.81M 1.73M | EV / Sales 2025 * | 6.93 x |
P/E ratio 2024 * |
1,445
x | P/E ratio 2025 * |
77.4
x | Employees | 34 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 57.11% |
1 day | -1.04% | ||
1 week | -7.74% | ||
Current month | +13.94% | ||
1 month | +15.56% | ||
3 months | +30.00% | ||
6 months | +90.03% | ||
Current year | +25.30% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 64 | 97-12-31 | |
Jörgen Svanström
DFI | Director of Finance/CFO | - | 23-05-01 |
Mats Dotevall
COO | Chief Operating Officer | 62 | 23-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 18-12-31 | |
Bengt Sjöholm
CHM | Chairman | 71 | 18-12-31 |
Founder | 64 | 97-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 57.2 | -1.04% | 11 342 |
24-05-02 | 57.8 | +1.05% | 29,102 |
24-04-30 | 57.2 | -1.72% | 17,783 |
24-04-29 | 58.2 | +4.68% | 34,300 |
24-04-26 | 55.6 | +8.17% | 74,035 |
Delayed Quote Nasdaq Stockholm, May 03, 2024 at 04:48 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.30% | 97.72M | |
-14.01% | 20.62B | |
-4.19% | 16.98B | |
+7.42% | 13.55B | |
+10.00% | 10.15B | |
-13.54% | 2.16B | |
+9.29% | 1.79B | |
+18.37% | 583M | |
-.--% | 428M | |
+30.77% | 151M |
- Stock Market
- Equities
- INTEG B Stock